CCNYSEChemicals & Allied ProductsFiscal year ends December 31
Chemours Co
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$12.62−0.12 (-0.94%)
Close on Oct 19, 2026
- Market cap
- $1.91B
- P/E (TTM)
- –
- Dividend yield
- 4.06%
Margins
Share of revenue, fiscal years 2013 to 2025
Gross margin
15.5%−5.9 pts over 5 years
Net margin
-6.6%−11.1 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +0.4% | -5.3% | +3.2% | +0.2% | |
| Gross profit | -21.0% | -17.7% | -3.3% | -0.6% | |
| Free cash flow | – | -51.5% | -37.6% | – | |
| Dividend per share | -48.8% | -20.0% | -12.5% | -1.2% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 6.2% | 29.2% | -94.0% | |
| Return on assets | 0.1% | 3.1% | -5.2% | |
| Current ratio | 1.44 | 1.83 | 1.78 | |
| Debt to equity | 35.44 | 4.95 | 16.56 | |
| Inventory turnover | 4.9× | 3.9× | 3.2× | |
| Capex to revenue | 6.3% | 5.4% | 3.7% | |
| Diluted shares | 183M | 166M | 150M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Chemours generated $3.02B from operations and spent $2.96B on capital expenditure, dividends and share buybacks. 52% of that went back into the business.
Generated
$3.02B
Used
$2.96B
Capital expenditure$1.53B52%Dividends$693.00M23%Share buybacks$737.00M25%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-6.6%
×Asset turnover0.78×
×Equity multiplier18.14×
=Return on equity, FY2025-94.0%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -6.6% | 0.78× | 18.14× | -94.0% |
| FY2024 | 1.2% | 0.73× | 12.19× | 10.7% |
| FY2023 | -4.2% | 0.77× | 8.69× | -27.7% |
| FY2022 | 8.5% | 0.90× | 6.94× | 52.8% |
| FY2021 | 9.6% | 0.87× | 7.73× | 64.2% |
| FY2020 | 4.4% | 0.69× | 9.55× | 29.2% |
| FY2019 | -0.9% | 0.76× | 8.58× | -6.1% |
| FY2018 | 15.0% | 0.91× | 7.82× | 106.2% |
| FY2017 | 12.1% | 0.93× | 13.91× | 155.4% |
| FY2016 | 0.1% | 0.87× | 54.68× | 6.2% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
4of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero-$386.00M
- Cash generatingOperating cash flow above zero$264.00M
- Return on assets improvedROA up on the prior year0.8% → -5.1%
- Earnings backed by cashOperating cash flow above net income$264.00M vs -$386.00M
- Less leverageLong-term debt to assets fell54.1% → 55.5%
- Better liquidityCurrent ratio rose1.66 → 1.78
- No dilutionShare count did not rise150M → 150M
- Gross margin improvedGross margin up on the prior year19.75% → 15.53%
- More efficientAsset turnover rose0.70 → 0.77